NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 75 filers reported holding NOVELION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $118,000 | -65.4% | 31,949 | -67.2% | 0.00% | – |
| Q1 2018 | $341,000 | -19.6% | 97,407 | -28.3% | 0.00% | – |
| Q4 2017 | $424,000 | -55.6% | 135,783 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $955,000 | +297.9% | 135,783 | +424.3% | 0.00% | – |
| Q2 2017 | $240,000 | – | 25,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|